YU210773A - Process for obtaining imidazoquinazolin-2-one derivatives - Google Patents
Process for obtaining imidazoquinazolin-2-one derivativesInfo
- Publication number
- YU210773A YU210773A YU02107/73A YU210773A YU210773A YU 210773 A YU210773 A YU 210773A YU 02107/73 A YU02107/73 A YU 02107/73A YU 210773 A YU210773 A YU 210773A YU 210773 A YU210773 A YU 210773A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- imidazoquinazolin
- derivatives
- obtaining
- obtaining imidazoquinazolin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22372372A | 1972-02-04 | 1972-02-04 | |
| US29145072A | 1972-09-22 | 1972-09-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU210773A true YU210773A (en) | 1983-02-28 |
Family
ID=26918072
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU02107/73A YU210773A (en) | 1972-02-04 | 1973-08-03 | Process for obtaining imidazoquinazolin-2-one derivatives |
| YU01510/81A YU151081A (en) | 1972-02-04 | 1981-06-15 | Process for producing precursors of a new hypotensive and agent, respectively, for inhibiting the aggregation of blood platelets |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU01510/81A YU151081A (en) | 1972-02-04 | 1981-06-15 | Process for producing precursors of a new hypotensive and agent, respectively, for inhibiting the aggregation of blood platelets |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS5623994B2 (enrdf_load_html_response) |
| AU (1) | AU475978B2 (enrdf_load_html_response) |
| BE (1) | BE794964A (enrdf_load_html_response) |
| CA (1) | CA1009652A (enrdf_load_html_response) |
| DE (1) | DE2305575A1 (enrdf_load_html_response) |
| FR (1) | FR2173988B1 (enrdf_load_html_response) |
| GB (1) | GB1418822A (enrdf_load_html_response) |
| HK (1) | HK15581A (enrdf_load_html_response) |
| YU (2) | YU210773A (enrdf_load_html_response) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE31617E (en) * | 1972-02-04 | 1984-06-26 | Bristol-Myers Company | Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones |
| NL7807507A (nl) | 1977-07-25 | 1979-01-29 | Hoffmann La Roche | Tricyclische verbindingen. |
| US4146718A (en) * | 1978-04-10 | 1979-03-27 | Bristol-Myers Company | Alkyl 5,6-dichloro-3,4-dihydro-2(1h)-iminoquinazoline-3-acetate hydrohalides |
| CA1131631A (en) * | 1979-06-20 | 1982-09-14 | Madhukar S. Chodnekar | Quinazoline derivatives and pharmaceutical preparations |
| ZW16481A1 (en) * | 1980-08-15 | 1982-03-10 | Hoffmann La Roche | Novel imidazoquinazoline derivatives |
| JPS6028979A (ja) * | 1983-07-14 | 1985-02-14 | Dai Ichi Seiyaku Co Ltd | イミダゾキナゾリン類化合物 |
| CZ281628B6 (cs) * | 1991-07-29 | 1996-11-13 | Warner-Lambert Company | Deriváty chinazolinu a farmaceutické přípravky na jejich bázi |
| HU219864B (hu) * | 1994-08-09 | 2001-08-28 | Eisai Co., Ltd. | cGMP-PDE inhibitor kondenzált piridazinszármazékok és alkalmazásuk |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| US8304420B2 (en) | 2006-11-28 | 2012-11-06 | Shire Llc | Substituted quinazolines for reducing platelet count |
| US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| GB0808968D0 (en) * | 2008-05-16 | 2008-06-25 | Shire Llc | Substitute quinazolines |
| GB0808947D0 (en) * | 2008-05-16 | 2008-06-25 | Shire Llc | Substituted quinazolines |
| ES2522968T3 (es) | 2008-06-04 | 2014-11-19 | Synergy Pharmaceuticals Inc. | Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos |
| ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| MX357121B (es) | 2011-03-01 | 2018-06-27 | Synergy Pharmaceuticals Inc Star | Proceso de preparacion de agonistas c de guanilato ciclasa. |
| WO2014131024A2 (en) | 2013-02-25 | 2014-08-28 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| WO2014151206A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| EP2968439A2 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| EP3004138B1 (en) | 2013-06-05 | 2024-03-13 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
| KR102456567B1 (ko) | 2013-08-09 | 2022-10-19 | 알데릭스, 인코포레이티드 | 인산염 수송을 억제하기 위한 화합물 및 방법 |
| US20200368223A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Methods for inhibiting phosphate transport |
| WO2022199627A1 (en) * | 2021-03-23 | 2022-09-29 | National Institute Of Biological Sciences, Beijing | Polycyclic compounds and uses thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE760013A (fr) * | 1969-12-18 | 1971-06-08 | Smith Kline French Lab | Imidazo et pyrimido -(2,1-b)quinazolines, leurs procedes de preparationet compositions pharmaceutiques en contenant |
-
0
- BE BE794964D patent/BE794964A/xx not_active IP Right Cessation
-
1973
- 1973-02-01 AU AU51668/73A patent/AU475978B2/en not_active Expired
- 1973-02-02 FR FR7303843A patent/FR2173988B1/fr not_active Expired
- 1973-02-02 JP JP1303873A patent/JPS5623994B2/ja not_active Expired
- 1973-02-02 CA CA162,747A patent/CA1009652A/en not_active Expired
- 1973-02-02 GB GB539073A patent/GB1418822A/en not_active Expired
- 1973-02-05 DE DE19732305575 patent/DE2305575A1/de active Granted
- 1973-08-03 YU YU02107/73A patent/YU210773A/xx unknown
-
1981
- 1981-04-23 HK HK155/81A patent/HK15581A/xx unknown
- 1981-06-15 YU YU01510/81A patent/YU151081A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2173988B1 (enrdf_load_html_response) | 1976-10-22 |
| GB1418822A (en) | 1975-12-24 |
| CA1009652A (en) | 1977-05-03 |
| AU475978B2 (en) | 1976-09-09 |
| HK15581A (en) | 1981-05-01 |
| BE794964A (fr) | 1973-08-02 |
| FR2173988A1 (enrdf_load_html_response) | 1973-10-12 |
| AU5166873A (en) | 1974-08-01 |
| DE2305575C2 (enrdf_load_html_response) | 1989-01-12 |
| DE2305575A1 (de) | 1973-08-09 |
| JPS4886894A (enrdf_load_html_response) | 1973-11-15 |
| JPS5623994B2 (enrdf_load_html_response) | 1981-06-03 |
| YU151081A (en) | 1983-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS183689B2 (en) | Process for preparing pyridylphenoxyalkane derivatives | |
| YU42539B (en) | Process for obtaining alkanolamine derivatives | |
| YU210773A (en) | Process for obtaining imidazoquinazolin-2-one derivatives | |
| YU270780A (en) | Process for obtaining dimethyl-2-oxo-3-phenoxypropylphosphonates | |
| YU119773A (en) | Process for obtaining morphinane derivatives | |
| YU228873A (en) | Process for preparing novel benzoyl-benzofuran derivatives | |
| YU3473A (en) | Process for obtaining delta-aryl-4-substituted piperidinoalkanol derivatives | |
| YU36527B (en) | Process for obtaining 3-hydroxy-cephalosporin | |
| YU35243B (en) | Process for obtaining diphenylyl-alkanoyl-aminopyridines | |
| YU296173A (en) | Process for obtaining new alkylthiocyclopentanone derivatives | |
| YU35775B (en) | Process for obtaining d-homosteroids | |
| HU172069B (hu) | Sposob poluchenija proizvodnykh 1-skobka-3-dvojjnozamehhennykh-fosfono-tioureido-skobka zakryta-2-skobka-3-zamehhennykh-ureido- ili -tioureido-skobka zakryta-benzolov | |
| YU299479A (en) | Process for obtaining novel aminoimidazoloisoquinoline derivatives | |
| HU171818B (hu) | Sposob poluchenija slozhnykh p-difenil-ehfirnykh proizvodnykh omega-arili oksa-prostaglandina | |
| YU98273A (en) | Process for obtaining isopropylamines | |
| HU167876B (en) | Process for producing 9-10-secoestrane derivatives | |
| HU173381B (hu) | Sposob poluchenija proizvodnykh karboksi-ciklopropanov | |
| CH613977A5 (en) | Process for preparing tricyclohexyl-tin derivatives | |
| YU35253B (en) | Process for preparing 2-imidazolidione derivatives | |
| YU240180A (en) | Process for obtaining deacetoxy-cephalosporin | |
| YU146973A (en) | Process for obtaining oxo-prostaglandins | |
| YU318473A (en) | Process for obtaining m-dioxane-5-methylamines | |
| YU102673A (en) | Process for obtaining rifamycine b | |
| YU113673A (en) | Process for obtaining novel 1-acyl-homo-pyrimidazole derivatives | |
| YU35273B (en) | Process for obtaining bicyclomycine |